Expanding Medicare coverage of anti-obesity medicines could increase annual spending by $3.1 to $6.1 billion, according to a new Health Affairs study.
Expanding Medicare coverage of anti-obesity medicines could increase annual spending by $3.1 to $6.1 billion, according to a new Health Affairs study.